May 11, 2021

05/11/2021 | 04:24am EDT Message : *Required fields DGAP-News: AMSilk GmbH / Key word(s): FinancingAMSilk raises EUR 29M to accelerate commercialization of its high-performance bio-based silk polymers2021-05-11 / 10:22The issuer is solely responsible for the content of this announcement.=----------------------------------------------------------------------------------------------------------------------=---------- PRESS RELEASE -----------AMSilk raises EUR 29M to accelerate commercialization of its high-performance bio-based silk polymers- Financing led by Novo Holdings with participation from Cargill and E.R. Capital Holdings- AMSilk to accelerate industrial scale-up and expand commercial operations into new marketsMunich, May 11, 2021 - AMSilk GmbH ("AMSilk"), the world's first industrial supplier of synthetic silk biopolymers,today announces the successful closing of a EUR 29 million Series C fundraise. The financing was led by Novo Growth,the growth equity arm of Novo Holdings, with participation from new investors Cargill and E.R. Capital Holdings as wellas existing investors MIG Verwaltungs AG and ATHOS KG.AMSilk is a world leader in supplying innovative high-performance bio-based silk materials with a vision to use itsproprietary technology platform to lead the change to better and more sustainable products. Its products are made fromplant-based raw material via bacterial fermentation, are extremely versatile with extraordinary mechanical andbiochemical properties, and have applications across many industries. The environmentally friendly, sustainable silkbiopolymers can be fully recycled and are 100% biodegradable. These materials are revolutionizing products such ashigh-performance sports clothing as well as driving state-of-the-art biomedical developments including medicalimplants.The financing will accelerate the ongoing scale-up of AMSilk's industrial projects worldwide and drive further theinternationalization of its commercial activities as it continues to expand its customer base into new markets.Ulrich Scherbel, Chief Executive Officer of AMSilk, said: "Together with our customers we work to createhigh-performance bio-based materials with the potential to revolutionize product offerings and drive change acrossvarious industries. It is exciting to have the support from high-technology investors, led by Novo Holdings, to makeour silk polymers available in industrial quantities to an even broader range of customers and industries." Dr WolfgangColberg, Chairman of the Advisory Board, added: "With the inspiring support of our new and existing shareholders we arein a strong position to establish AMSilk as one of the leading bio-materials companies in the world. "Kartik Dharmadhikari, Partner at Novo Growth, stated: "AMSilk's technology has the potential to revolutionize a numberof industries and be part of the decarbonization push needed to overcome the biggest environmental challenges of ourtime. The company has made immense progress in enhancing its high-performance bio-based materials and we are delightedto lead this financing which will enable them to expand the business globally. This investment underscores NovoHoldings' commitment to backing companies that will have a long-term, sustainable impact on society. "Asheesh Choudhary, Global Business Development Director, Bioindustrial at Cargill, added: "The apparel industry isdemanding bio-based materials that are good for people and the planet. We are excited by AMSilk's innovation as itoffers a sustainable and functional product to its customers. We are investing in AMSilk because our strategicinterests are well aligned, and we are happy to be a part of enabling its growth. "On behalf of the existing shareholders, Melissa Simon, ATHOS KG, stated: "As original investors in the company, we havewitnessed the immense progress achieved to date and look forward to continuing to support AMSilk delivering on itsvision." Michael Motschmann, General Partner at MIG AG, added: "As an AMSilk seed investor, we are proud of the greatstrides the company has made since inception. Our continued investment in AMSilk mirrors our vision to invest in earlybiotech and deep tech companies and advance innovations that can move the world forward. "Kartik Dharmadhikari, Partner, Anders Bendsen Spohr, Senior Partner at Novo Holdings, and Melissa Simon from ATHOS KG,will join the Supervisory Board.-ENDS-For further information please contact:AMSilk GmbHAnja KehlTel: +49 (0)89 57 95 393-0E-mail: pr@amsilk.comNovo HoldingsOptimum Strategic CommunicationsMary Clark, Manel MateusTel: +44 (0) 20 39 22 190 6E-mail: novo@optimumcomms.comAbout AMSilkAMSilk GmbH is the world's first industrial supplier of vegan silk biopolymers and has its headquarters in Planegg,near Munich, Germany. AMSilk's high-performance biopolymers have the unique functional properties of the naturalproduct they are based on. AMSilk offers its innovative range of high-performance Biosteel(R) fibers for textiles andindustrial applications worldwide and has announced collaborations and partnerships with world leading brands likeAdidas and Airbus. The organic high-performance material can be used in multiple ways and is suited for medical devicesas well as for personal care products. AMSilk high-performance biopolymers give such products unique properties. Amongother things, the polymers are biocompatible, safe and robust. AMSilk invites you to discover more atwww.amsilk.comAbout Novo HoldingsNovo Holdings is recognized as a leading life science investor with a focus on creating long-term value. As a lifesciences investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significantownership positions in growth and well-established companies. Novo Holdings also manages a broad portfolio ofdiversified financial assets. For more information: https://www.novoholdings.dk/news/ About CargillCargill's 155,000 employees across 70 countries work relentlessly to achieve our purpose of nourishing the world in asafe, responsible and sustainable way. Every day, we connect farmers with markets, customers with ingredients, andpeople and animals with the food they need to thrive. We combine 155 years of experience with new technologies andinsights to serve as a trusted partner for food, agriculture, financial and industrial customers in more than 125countries. Side-by-side, we are building a stronger, sustainable future for agriculture.Cargill.comAbout MIG AGMIG Verwaltungs AG (MIG AG), Munich, is one of the leading German VC investors. MIG invests through MIG Fonds in young,deep tech and life science companies in German-speaking Europe and beyond. To date, the company has invested more thanEUR 600 million in over 40 companies. MIG's portfolio companies develop innovations in biopharmaceuticals, AI / machinelearning, quantum technologies, digitization / IoT, medtech and digital health. The MIG investment portfolio currentlyconsists of 30 companies. MIG AG has successfully sold its portfolio companies SuppreMol (to Baxter in 2015), sunhilltechnologies (to Volkswagen in 2015), Ganymed (to Astellas in 2016) and Siltectra (to Infineon in 2018) and leads Brain(in 2017), NFON (in 2018), BioNTech (in 2019) and Immatics (in 2020) to listings on stock exchanges. https://www.mig.ag About ATHOS KGATHOS KG is the family office of a German entrepreneurial family investing among others direct into companies with along-term and entrepreneurial focus.=----------------------------------------------------------------------------------------------------------------------2021-05-11 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de=---------------------------------------------------------------------------------------------------------------------- 1195159 2021-05-11